We are live on ! Find out more
VCA

Verdence Capital Advisors Portfolio holdings

AUM $1.9B
1-Year Est. Return 36.41%
This Fund
S&P 500
This Quarter Est. Return
-11.98%
1 Year Est. Return
+36.41%
3 Year Est. Return
+97.11%
5 Year Est. Return
+121.09%
10 Year Est. Return
AUM
$773M
AUM Growth
-$110M
Cap. Flow
+$5.12M
Cap. Flow %
0.66%
Top 10 Hldgs %
21.02%
Holding
545
New
35
Increased
238
Reduced
206
Closed
36

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$4.05M
2
CVX icon
Chevron
CVX
+$3.83M
3
ABBV icon
AbbVie
ABBV
+$2.24M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.32M
5
COP icon
ConocoPhillips
COP
+$1.24M

Sector Composition

Rank Sector Weight
1 Technology 15.95%
2 Financials 13.32%
3 Healthcare 11.6%
4 Industrials 6.99%
5 Consumer Staples 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CABO icon
226
Cable One
CABO
$254M
$698K 0.09%
541
+204
+61% +$260K
VEEV icon
227
Veeva Systems
VEEV
$33.5B
$697K 0.09%
3,519
+1,537
+78% +$283K
XLV icon
228
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$697K 0.09%
5,433
+103
+2% +$13.5K
BL icon
229
BlackLine
BL
$1.92B
$695K 0.09%
10,433
+2,952
+39% +$202K
ANSS
230
DELISTED
Ansys
ANSS
$693K 0.09%
2,898
+1,101
+61% +$291K
PSX icon
231
Phillips 66
PSX
$82.7B
$691K 0.09%
8,426
-14
-0.2% -$1.29K
WBA
232
DELISTED
Walgreens Boots Alliance
WBA
$690K 0.09%
18,217
-5,804
-24% -$250K
BKNG icon
233
Booking.com
BKNG
$149B
$687K 0.09%
+9,825
New +$838K
HALO icon
234
Halozyme
HALO
$9.76B
$683K 0.09%
15,528
+1,507
+11% +$65.2K
TDG icon
235
TransDigm Group
TDG
$71.9B
$675K 0.09%
1,258
+370
+42% +$218K
ASML icon
236
ASML
ASML
$631B
$673K 0.09%
1,414
+317
+29% +$177K
CI icon
237
Cigna
CI
$74.5B
$670K 0.09%
2,541
-152
-6% -$39.2K
ADI icon
238
Analog Devices
ADI
$176B
$668K 0.09%
4,570
+92
+2% +$14.5K
SNN icon
239
Smith & Nephew
SNN
$13.5B
$664K 0.09%
23,793
+11,252
+90% +$350K
SBAC icon
240
SBA Communications
SBAC
$19B
$663K 0.09%
2,071
+171
+9% +$57.6K
VOE icon
241
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$662K 0.09%
5,112
+2,162
+73% +$306K
IGSB icon
242
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$658K 0.09%
13,018
+1,576
+14% +$80.2K
GLD icon
243
SPDR Gold Trust
GLD
$131B
$647K 0.08%
3,841
+440
+13% +$76.8K
HEI.A icon
244
HEICO Corp Class A
HEI.A
$36.6B
$647K 0.08%
6,141
+1,864
+44% +$215K
BIIB icon
245
Biogen
BIIB
$29.8B
$640K 0.08%
3,139
-261
-8% -$53.4K
ALGN icon
246
Align Technology
ALGN
$12.4B
$636K 0.08%
2,686
+370
+16% +$114K
ALL icon
247
Allstate
ALL
$67.6B
$635K 0.08%
5,008
-3,749
-43% -$491K
MS icon
248
Morgan Stanley
MS
$332B
$635K 0.08%
8,351
+544
+7% +$44.6K
TECH icon
249
Bio-Techne
TECH
$11.2B
$631K 0.08%
7,276
+2,600
+56% +$244K
MMM icon
250
3M
MMM
$91.4B
$622K 0.08%
5,750
+242
+4% +$29.2K

Similar funds

Verdence Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Verdence Capital Advisors held 545 positions worth $773M, down 12% from $883M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdence Capital Advisors's Q2 2022 filing shows 35 new, 238 increased, 206 reduced and 36 closed positions. Its largest new stake was Dimensional US Marketwide Value ETF: 120,891 shares worth $3.82M. The largest sale was Labcorp, an estimated $4.05M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Verdence Capital Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 120,891 shares worth $3.82M.
  • Verdence Capital Advisors added most to iShares MSCI EAFE ETF in Q2 2022, an estimated $5.14M increase.
  • Verdence Capital Advisors's biggest Q2 2022 reduction was Chevron, cutting an estimated $3.83M.
  • Verdence Capital Advisors fully exited Labcorp in Q2 2022, selling an estimated $4.05M.
  • Verdence Capital Advisors's ten largest holdings make up 21% of its $773M portfolio in Q2 2022.
  • Verdence Capital Advisors opened 35 new positions and closed 36 in Q2 2022.
  • Verdence Capital Advisors's portfolio value fell 12% quarter-over-quarter to $773M.

Based on Verdence Capital Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.